Literature DB >> 986305

Circling behavior in rats with 6-hydroxydopamine or electrolytic nigral lesions,.

E T Iwamoto, H H Loh, E L Way.   

Abstract

Unilateral destruction of dopaminergic cell bodies in the substantia nigra zona compacta (SNC) was performed in rats using either electrocoagulation or chemical lesioning (6-hydroxydopamine, 6-OHDA). Neostriatal dopamine concentration ipsilateral to an electrolytic lesion was 34% of the contralateral side 2-3 weeks after operation; serotonin and noradrenaline brain levels were not altered. In contrast, dopamine and noradrenaline forebrain concentrations ipsilateral to a 6-OHDA lesion were 20 and 31%, respectively, of the contralateral side. After 6-OHDA, dopamine concentrations in the ipsilateral neostriatum were reduced to levels below the sensitivity of the fluorometric assay; cortical, brainstem and neostriatal serotonin levels, on the other hand, were not altered after 6-OHDA. Ipsilateral circling behavior was elicited by d-amphetamine after electrolytic and chemical lesioning. In contrast, the direction of circling produced after apomorphine differed between the two lesion models: contralateral circling behavior was exhibited by 6-OHDA-lesioned rats, whereas ipsilateral circling was produced in animals with electrolytic lesions. Contralateral circling was induced in both lesion-type models by haloperidol or pimozide. S.c. atropine administration induced ipsilateral circling in rats with 6-OHDA lesions, whereas contralateral circling was observed after arecoline. Animals with electrolytic SNC lesions turn ipsilaterally after s.c. administrations of either arecoline or atropine. The data indicate that the electrolytic and 6-OHDA circling behavior models represent two different neuropharmacological states and it is, therefore, suggested that comparisons of data obtained from models using different methods of lesioning be made with caution.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 986305     DOI: 10.1016/0014-2999(76)90042-x

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  7 in total

Review 1.  Role of nitric oxide on motor behavior.

Authors:  E A Del Bel; F S Guimarães; M Bermúdez-Echeverry; M Z Gomes; A Schiaveto-de-souza; F E Padovan-Neto; V Tumas; A P Barion-Cavalcanti; M Lazzarini; L P Nucci-da-Silva; D de Paula-Souza
Journal:  Cell Mol Neurobiol       Date:  2005-03       Impact factor: 5.046

Review 2.  Contribution of serotonergic transmission to the motor and cognitive effects of high-frequency stimulation of the subthalamic nucleus or levodopa in Parkinson's disease.

Authors:  Sylvia Navailles; Philippe De Deurwaerdère
Journal:  Mol Neurobiol       Date:  2012-01-06       Impact factor: 5.590

3.  Superior Colliculus Controls the Activity of the Rostromedial Tegmental Nuclei in an Asymmetrical Manner.

Authors:  Kamil Pradel; Gniewosz Drwiȩga; Tomasz Błasiak
Journal:  J Neurosci       Date:  2021-03-19       Impact factor: 6.167

Review 4.  Molecular Pathology and Pharmacological Treatment of Autism Spectrum Disorder-Like Phenotypes Using Rodent Models.

Authors:  Hsiao-Ying Kuo; Fu-Chin Liu
Journal:  Front Cell Neurosci       Date:  2018-11-20       Impact factor: 5.505

Review 5.  Animal models of Parkinson's disease and L-dopa induced dyskinesia: how close are we to the clinic?

Authors:  Emma Lane; Stephen Dunnett
Journal:  Psychopharmacology (Berl)       Date:  2007-09-25       Impact factor: 4.530

Review 6.  Hemispheric differences in the mesostriatal dopaminergic system.

Authors:  Ilana Molochnikov; Dana Cohen
Journal:  Front Syst Neurosci       Date:  2014-06-11

7.  Genetic elimination of dopamine vesicular stocks in the nigrostriatal pathway replicates Parkinson's disease motor symptoms without neuronal degeneration in adult mice.

Authors:  Elsa Isingrini; Chloé Guinaudie; Léa C Perret; Quentin Rainer; Luc Moquin; Alain Gratton; Bruno Giros
Journal:  Sci Rep       Date:  2017-09-29       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.